Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CRH in chronic inflammatory stress.

D S Jessop1, M S Harbuz, S L Lightman

  • 1University Research Centre for Neuroendocrinology, University of Bristol, BS2 8HW, Bristol, UK. David.Jessop@Bristol.ac.uk

Peptides
|May 5, 2001
PubMed
Summary

Corticotropin-releasing hormone (CRH) regulates inflammation centrally via the HPA axis and peripherally. Understanding CRH pathways and interactions offers potential for novel anti-inflammatory drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External amplitude and frequency modulation of a terahertz quantum cascade laser using metamaterial/graphene devices.

Scientific reports·2017
Same author

Investigation of hollow cylindrical metal terahertz waveguides suitable for cryogenic environments.

Optics express·2017
Same author

Hyperuniform disordered terahertz quantum cascade laser.

Scientific reports·2016
Same author

Efficient coupling of double-metal terahertz quantum cascade lasers to flexible dielectric-lined hollow metallic waveguides.

Optics express·2015
Same author

Hollow metallic waveguides integrated with terahertz quantum cascade lasers.

Optics express·2014
Same author

The effect of hypothalamic lesions on hypothalamo-pituitary-adrenal axis activity and inflammation in adjuvant-induced arthritis.

Stress (Amsterdam, Netherlands)·2012

Area of Science:

  • Neuroendocrinology
  • Immunology
  • Pharmacology

Background:

  • Corticotropin-releasing hormone (CRH) centrally regulates inflammation through the hypothalamic-pituitary-adrenal (HPA) axis and glucocorticoid secretion.
  • The role of HPA axis defects in autoimmune disease etiology remains unclear, despite its critical function in controlling inflammation severity.
  • Peripheral CRH, secreted by leukocytes and neurons, also contributes to inflammatory processes.

Purpose of the Study:

  • To investigate the central and peripheral pathways of Corticotropin-releasing hormone (CRH) expression.
  • To explore the interactions between CRH and other inflammatory mediators, such as substance P.
  • To identify potential therapeutic targets for a new generation of anti-inflammatory agents.

Main Methods:

  • Review of existing literature on CRH, HPA axis, and inflammation.
  • Analysis of pathways involved in CRH expression in central and peripheral systems.
  • Examination of CRH interactions with inflammatory mediators.

Main Results:

  • CRH plays a dual role in inflammation, acting both centrally via the HPA axis and peripherally.
  • Evidence for HPA axis defects in autoimmune diseases is not conclusive.
  • Peripheral CRH contributes significantly to inflammatory responses.

Conclusions:

  • Elucidating CRH pathways, both central and peripheral, is crucial for understanding its role in inflammation.
  • Understanding CRH interactions with mediators like substance P holds promise for developing novel anti-inflammatory therapies.
  • Targeting CRH pathways may lead to a new class of anti-inflammatory drugs.

Related Experiment Videos